GEHC - Company ID 0001932393
The table below shows GE HealthCare Technologies Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $5.51B | $5.29B | $5.13B | $5.14B | $5.01B | $4.78B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | $2.22B | $2.18B | $1.98B | $1.99B | $1.99B | $2.01B |
| R&D | $320.00M | $323.00M | $345.00M | $292.00M | $302.00M | $344.00M |
GE HealthCare Technologies Inc. reported annual revenue of $20.63B for fiscal year 2025. That is up 4.8% from $19.67B in fiscal 2024. Over the 5 fiscal years shown, annual revenue grew from $17.59B (FY 2021) to $20.63B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $1.10B |
| $1.12B |
| $1.12B |
| $1.04B |
| $1.03B |
| $1.04B |
| Operating income | $805.00M | $739.00M | $515.00M | $653.00M | $654.00M | $629.00M |
| Income tax | $129.00M | $119.00M | $94.00M | $179.00M | $113.00M | $104.00M |
| Net income | $615.00M | $561.00M | $389.00M | $446.00M | $486.00M | $564.00M |
| EPS (diluted) | $1.36 | $1.24 | $0.85 | $0.98 | $1.06 | $1.23 |